Also trades as: FNCH (OTC) · $vol 0M
FNCHQ OTC
Finch Therapeutics Group, Inc.
1W: +0.0%
1M: +1.5%
3M: +2.5%
YTD: +2.5%
$10.35
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$16.6M
52W Range2-16.1
Volume600
Avg Volume1,216
Beta0.99
Dividend—
Analyst Ratings
Company Info
CEOMatthew Blischak
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2021-03-18
Websitefinchtherapeutics.com
75 State Street
Boston, MA 02109
US
Boston, MA 02109
US
About Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Latest News
No recent news
Recent Insider Trades
No insider trades found